Trials / Unknown
UnknownNCT03220464
Early Diagnosis of Active Tuberculosis Using Ultra Low-dose Chest CT
Early Diagnosis of Active Tuberculosis Using Ultra Low-dose Chest CT to Predict Progression to Active Tuberculosis Among Contacts
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 116 (estimated)
- Sponsor
- Seoul National University Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Accepted
Summary
The aim of this study is to evaluate ultra low dose chest computed tomography (ULDCT) for early diagnosis of active tuberculosis in cohort of close contacts of active pulmonary tuberculosis for 1 year follow up
Detailed description
The early diagnosis of active tuberculosis in close contacts have not yet been established. To evaluate the early detection of active pulmonary tuberculosis using ULDCT, the investigators will establish the observational cohort of close contacts living in the same space with active pulmonary tuberculosis. Participants will visit our center at enrollment, after 3 months, and 12 months and will be received ULDCT, chest X-ray and Interferon-gamma assays at each visit. One chest radiologist will interpret findings of ULDCT and chest X-ray. Patients diagnosed with active tuberculosis will be excluded from the study and treated based on World Health Organization guidelines.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| RADIATION | Ultra low dose chest computed tomography (ULDCT) | Participants in the study will receive ULDCT at enrollment, after 3-month visit, and after 12-month visit. |
| RADIATION | Chest X-ray | Participants in the study will receive chest x-ray at enrollment, after 3-month visit, and after 12-month visit. |
| DIAGNOSTIC_TEST | Interferon-gamma Release Assay (IGRA) | Participants in the study will receive IGRA test at enrollment, after 3-month visit, and after 12-month visit. About 11mL of blood will be drawn from the participants for test of T-SPOT®.TB test and QuantiFERON test. |
Timeline
- Start date
- 2017-06-20
- Primary completion
- 2019-04-30
- Completion
- 2020-04-30
- First posted
- 2017-07-18
- Last updated
- 2017-07-21
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT03220464. Inclusion in this directory is not an endorsement.